HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 4956-4964

  Wuillemin, Natascha ^a   Adam, Jacqueline ^a   Fontana, Stefano ^b   Krähenbü hl, Stephan ^c   Pichler, Werner J ^a   Yerly, Daniel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Regional Blood Transfusion Service of the Swiss Red Cross St Gallen   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCLOXACILLIN; HAPTEN; HLA B ANTIGEN; PROTEASOME;

ALLELE; ARTICLE; CD8+ T LYMPHOCYTE; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; MOLECULAR INTERACTION; PHARMACOLOGICAL INTERACTION WITH IMMUNE RECEPTOR; PRIORITY JOURNAL; PROTEIN PROCESSING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DRUG-INDUCED LIVER INJURY; FLOXACILLIN; HAPLOTYPES; HAPTENS; HLA-B ANTIGENS; HUMANS; LIVER; LYMPHOCYTE ACTIVATION;

EID: 84877792047     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202949     Document Type: Article

References (34)

1. Olsson, R., B. E.Wiholm, C. Sand, L. Zettergren, R. Hultcrantz, and M. Myrhed. 1992. Liver damage from flucloxacillin, cloxacillin and dicloxacillin. J. Hepatol. 15: 154-161.
2. Fairley, C. K., J. J. McNeil, P. Desmond, R. Smallwood, H. Young, A. Forbes, P. Purcell, and I. Boyd. 1993. Risk factors for development of flucloxacillin associated jaundice. BMJ 306: 233-235. (Pubitemid 23027961)
3. Russmann, S., J. A. Kaye, S. S. Jick, and H. Jick. 2005. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database. Br. J. Clin. Pharmacol. 60: 76-82. (Pubitemid 40942784)
4. Turner, I. B., R. P. Eckstein, J. W. Riley, and M. R. Lunzer. 1989. Prolonged hepatic cholestasis after flucloxacillin therapy. Med. J. Aust. 151: 701-705. (Pubitemid 20021281)
5. Miros, M., P. Kerlin, N. Walker, and O. Harris. 1990. Flucloxacillin induced delayed cholestatic hepatitis. Aust. N. Z. J. Med. 20: 251-253. (Pubitemid 20283046)
6. Daly, A. K., P. T. Donaldson, P. Bhatnagar, Y. Shen, I. Pe'er, A. Floratos, M. J. Daly, D. B. Goldstein, S. John, M. R. Nelson, et al DILIGEN Study; International SAE Consortium. 2009. HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat. Genet. 41: 816-819.
7. Spanou, Z., M. Keller, M. Britschgi, N. Yawalkar, T. Fehr, J. Neuweiler, M. Gugger, M. Mohaupt, and W. J. Pichler. 2006. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. J. Am. Soc. Nephrol. 17: 2919-2927. (Pubitemid 44484683)
8. Maria, V. A., and R. M. Victorino. 1997. Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut 41: 534-540.
9. El-Ghaiesh, S., M. M. Monshi, P. Whitaker, R. Jenkins, X. Meng, J. Farrell, A. Elsheikh, D. Peckham, N. French, M. Pirmohamed, et al. 2012. Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. J. Pharmacol. Exp. Ther. 341: 597-610.
10. Jenkins, R. E., X. Meng, V. L. Elliott, N. R. Kitteringham, M. Pirmohamed, and B. K. Park. 2009. Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo. Proteomics Clin. Appl. 3: 720-729.
11. Levine, B. B., and Z. Ovary. 1961. Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-Alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G. J. Exp. Med. 114: 875-904.
12. Adam, J., W. J. Pichler, and D. Yerly. 2011. Delayed drug hypersensitivity: models of T-cell stimulation. Br. J. Clin. Pharmacol. 71: 701-707.
13. Pichler, W. J. 2002. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr. Opin. Allergy Clin. Immunol. 2: 301-305. (Pubitemid 36869638)
14. Wei, C. Y., W. H. Chung, H. W. Huang, Y. T. Chen, and S. I. Hung. 2011. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J. Allergy Clin. Immunol. 129: 1562-1569.e1565.
15. Yang, L., J. Chen, and L. He. 2009. Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome. PLOS Comput. Biol. 5: e1000441.
16. Norcross, M. A., S. Luo, L. Lu, M. T. Boyne, M. Gomarteli, A. D. Rennels, J. Woodcock, D. H. Margulies, C. McMurtrey, S. Vernon, et al. 2012. Abacavir induces loading of novel self-peptides into HLA-B57: 01: an autoimmune model for HLA-Associated drug hypersensitivity. AIDS 26: F21-F29.
17. Ostrov, D. A., B. J. Grant, Y. A. Pompeu, J. Sidney, M. Harndahl, S. Southwood, C. Oseroff, S. Lu, J. Jakoncic, C. A. de Oliveira, et al. 2012. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc. Natl. Acad. Sci. USA 109: 9959-9964.
18. Illing, P. T., J. P. Vivian, N. L. Dudek, L. Kostenko, Z. Chen, M. Bharadwaj, J. J. Miles, L. Kjer-Nielsen, S. Gras, N. A. Williamson, et al. 2012. Immune selfreactivity triggered by drug-modified HLA-peptide repertoire. Nature 486: 554-558.
19. Mauri-Hellweg, D., M. Zanni, E. Frei, F. Bettens, C. Brander, D. Mauri, E. Padovan, H. U. Weltzien, and W. J. Pichler. 1996. Cross-reactivity of T cell lines and clones to beta-lactam antibiotics. J. Immunol. 157: 1071-1079.
20. Beeler, A., O. Engler, B. O. Gerber, and W. J. Pichler. 2006. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J. Allergy Clin. Immunol. 117: 455-462. (Pubitemid 43190160)
21. Gremion, C., B. Grabscheid, B. Wo lk, D. Moradpour, J. Reichen, W. Pichler, and A. Cerny. 2004. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction. J. Virol. 78: 2152-2157. (Pubitemid 38176748)
22. Adam, J., K. K. Eriksson, B. Schnyder, S. Fontana, W. J. Pichler, and D. Yerly. 2012. Avidity determines T-cell reactivity in abacavir hypersensitivity. Eur. J. Immunol. 42: 1706-1716.
23. Keller, M., M. Lerch, M. Britschgi, V. Tâche, B. O. Gerber, M. Luthi, P. Lochmatter, G. Kanny, A. J. Bircher, C. Christiansen, and W. J. Pichler. 2010. Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells. Clin. Exp. Allergy 40: 257-268.
24. Zou, P., J. Kawada, L. Pesnicak, and J. I. Cohen. 2007. Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells. J. Virol. 81: 10029-10036. (Pubitemid 350067706)
25. Shimizu, Y., D. E. Geraghty, B. H. Koller, H. T. Orr, and R. DeMars. 1988. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85: 227-231.
26. Schnyder, B., D. Mauri-Hellweg, M. Zanni, F. Bettens, and W. J. Pichler. 1997. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J. Clin. Invest. 100: 136-141. (Pubitemid 27311251)
27. Ko, T. M., W. H. Chung, C. Y. Wei, H. Y. Shih, J. K. Chen, C. H. Lin, Y. T. Chen, and S. I. Hung. 2011. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. J. Allergy Clin. Immunol. 128: 1266-1276.e1211.
28. + T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28: 822-832. (Pubitemid 351784513)
29. Harndahl, M., M. Rasmussen, G. Roder, I. Dalgaard Pedersen, M. Sørensen, M. Nielsen, and S. Buus. 2012. Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity. Eur. J. Immunol. 42: 1405-1416.
30. Zanni, M. P., S. von Greyerz, B. Schnyder, K. A. Brander, K. Frutig, Y. Hari, S. Valitutti, and W. J. Pichler. 1998. HLA-restricted, processing-And metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. J. Clin. Invest. 102: 1591-1598. (Pubitemid 28492227)
31. von Greyerz, S., M. Zanni, B. Schnyder, and W. J. Pichler. 1998. Presentation of non-peptide antigens, in particular drugs, to specific T cells. Clin. Exp. Allergy 28(Suppl 4): 7-11.
32. Yun, J., J. Adam, D. Yerly, and W. J. Pichler. 2012. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA. Allergy 67: 1338-1346.
33. Monshi, M., L. Faulkner, A. Gibson, R. E. Jenkins, J. Farrell, C. J. Earnshaw, A. Alfirevic, K. Cederbrant, A. K. Daly, N. French, et al. 2013. HLA-B57: 01-restricted activation of drug-specific T-cells provides the immunological basis for flucloxacillin-induced liver injury. Hepatology 57: 727-739.
34. Mennicke, M., A. Zawodniak, M. Keller, L. Wilkens, N. Yawalkar, F. Stickel, A. Keogh, D. Inderbitzin, D. Candinas, and W. J. Pichler. 2009. Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am. J. Transplant. 9: 2197-2202.